EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function

Emily N Kirby, Xavier B Montin, Timothy P Allen iD, Jaslan Densumite, Brooke N Trowbridge, Michael R Beard iD

Innate Immunity · 2024

DOI: 10.1177/17534259231225611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innate Immunity, 2024. Verfasst von Emily N Kirby und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Virus Replication, Interferons, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon Stimulated Gene (ISG) expression plays a key role in the control of viral replication and development of a robust adaptive response. Understanding this dynamic relationship between the pathogen and host is critical to our understanding of viral life-cycles and development of potential novel anti-viral strategies. Traditionally, plasmid based exogenous prompter driven expression of ISGs has been used to investigate anti-viral ISG function, however there are deficiencies in this approach. To overcome this, we investigated the utility of CRISPR activation (CRISPRa), which allows for targeted transcriptional activation of a gene from its endogenous promoter. Using the CRISPRa-SAM system to induce targeted expression of a panel of anti-viral ISGs we showed robust induction of mRNA and protein expression. We then employed our CRISPRa-SAM ISG panel in several antiviral screen formats to test for the ability of ISGs to prevent viral induced cytopathic cell death (CPE) and replication of Dengue Virus (DENV), Zika Virus (ZIKV), West Nile Virus Kunjin (WNV KUN ), Hepatitis A Virus (HAV) and Human Coronavirus 229E (HCoV-229E). Our CRISPRa approach confirmed the anti-viral activity of ISGs like IFI6, IFNβ and IFNλ2 that prevented viral induced CPE, which was supported by high-content immunofluorescence imaging analysis. This work highlights CRISPRa as a rapid, agile, and powerful methodology to identify and characterise ISGs and viral restriction factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationInterferonsAntiviral AgentsHumansCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsHEK293 CellsTranscriptional ActivationAnimals

Stichwörter der Autor:innen

AntiviralCRISPR activationinterferon stimulated genesvirus

Substanzen

InterferonsAntiviral Agents

Autor:innen und Institutionen

  • Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, South Australia, Australia.
  • Discipline of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia, Australia.
  • Department of Immunology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Timothy P Allen, Michael R Beard

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Kirby, E. N., Montin, X. B., Allen, T. P., Densumite, J., Trowbridge, B. N., & Beard, M. R. (2024). CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function. Innate Immunity. https://doi.org/10.1177/17534259231225611

Vancouver

Kirby EN, Montin XB, Allen TP, Densumite J, Trowbridge BN, Beard MR. CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function. Innate Immunity. 2024. doi:10.1177/17534259231225611

BibTeX
@article{Kirby2024,
  author = {Kirby, Emily N and Montin, Xavier B and Allen, Timothy P and Densumite, Jaslan and Trowbridge, Brooke N and Beard, Michael R},
  title = {CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function},
  journal = {Innate Immunity},
  year = {2024},
  doi = {10.1177/17534259231225611}
}
Kostenlos starten →